The brazilian health plan Prevent Senior did not inform its patients with COVID-19 who would be treated with hydroxychloroquine and ivermectin. The studies, which began on March 25, 2020, of the weeks after the World Health Organization (WHO) announced the coronavirus pandemic, which was hidden from patients and their families.
In a message sent to Prevent Senior employees, Fernando Oikawa, director of the health plan, said:
“We will start the hydroxychloroquine and ivermectin protocol. Please do not inform the patient or family member about the drug or program.”
The omisión of Prevent Senior was revealed by GloboNews this jueves 16. According to the issuer, the health plan mintió in the report on the medical experiment carried out on people infected with COVID-19. In the final text, the company indicated that only patients died after the combined use of the medications. In reality, future new.
The Prevent Senior experiment carried out on his patients was supported by President Jair Bolsonaro and the results pointed out by the study were used by drug advocates, which remain without scientific evidence.
Los primeros resultados del estudio fueron publicados por Prevent Senior el 15 de abril de 2020. Tres días después, en su cuenta personal de Twitter, Bolsonaro dio a conocer el experimento realizado por el plan de salud.
“From a group of 636 patients monitored by physicians, 224 did not use hydroxychloroquine. Of these, 12 were hospitalized and 5 died. Of the 412 who chose the drug, only 8 were hospitalized and, in addition to not being intubated, the number of deceased were cero. The complete study will be published soon”, says the president.
The file, with a series of complaints against Prevent Senior, based on the testimonies of doctors and former doctors of the health plan, is in the hands of the Parliamentary Inquiry Committee investigating the role of the Brazilian federal government in the conduct of the crisis generated by the coronavirus in the country.
In note, Prevent Senior informed that it has always acted within the ethical and legal parameters.
Edited by: Thales Schmidt